Literature DB >> 22853435

A preliminary study of the safety of red light phototherapy of tissues harboring cancer.

Max Myakishev-Rempel1, Istvan Stadler, Philip Brondon, David R Axe, Mark Friedman, Frances Barg Nardia, Raymond Lanzafame.   

Abstract

OBJECTIVE: Red light phototherapy is known to stimulate cell proliferation in wound healing. This study investigated whether low-level light therapy (LLLT) would promote tumor growth when pre-existing malignancy is present. BACKGROUND DATA: LLLT has been increasingly used for numerous conditions, but its use in cancer patients, including the treatment of lymphedema or various unrelated comorbidities, has been withheld by practitioners because of the fear that LLLT might result in initiation or promotion of metastatic lesions or new primary tumors. There has been little scientific study of oncologic outcomes after use of LLLT in cancer patients.
METHODS: A standard SKH mouse nonmelanoma UV-induced skin cancer model was used after visible squamous cell carcinomas were present, to study the effects of LLLT on tumor growth. The red light group (n=8) received automated full body 670 nm LLLT delivered twice a day at 5 J/cm(2) using an LED source. The control group (n=8) was handled similarly, but did not receive LLLT. Measurements on 330 tumors were conducted for 37 consecutive days, while the animals received daily LLLT.
RESULTS: Daily tumor measurements demonstrated no measurable effect of LLLT on tumor growth.
CONCLUSIONS: This experiment suggests that LLLT at these parameters may be safe even when malignant lesions are present. Further studies on the effects of photoirradiation on neoplasms are warranted.

Entities:  

Mesh:

Year:  2012        PMID: 22853435      PMCID: PMC3423866          DOI: 10.1089/pho.2011.3186

Source DB:  PubMed          Journal:  Photomed Laser Surg        ISSN: 1549-5418            Impact factor:   2.796


  40 in total

Review 1.  Low-intensity laser therapy: a review.

Authors:  A Schindl; M Schindl; H Pernerstorfer-Schön; L Schindl
Journal:  J Investig Med       Date:  2000-09       Impact factor: 2.895

Review 2.  Twenty-five years of active laser prevention of scars: what have we learned?

Authors:  F M Leclère; Serge R Mordon
Journal:  J Cosmet Laser Ther       Date:  2010-10       Impact factor: 2.247

Review 3.  Laser photobiomodulation of proliferation of cells in culture: a review of human and animal studies.

Authors:  Philip V Peplow; Tzu-Yun Chung; G David Baxter
Journal:  Photomed Laser Surg       Date:  2010-08       Impact factor: 2.796

4.  Photobiomodulation and cancer and other musings.

Authors:  Raymond J Lanzafame
Journal:  Photomed Laser Surg       Date:  2011-01       Impact factor: 2.796

Review 5.  Lasers in dental traumatology and low level laser therapy (LLLT).

Authors:  C Caprioglio; G Olivi; M D Genovese
Journal:  Eur Arch Paediatr Dent       Date:  2011-04

6.  Stimulation of the growth of human tumor by low-power laser irradiation.

Authors:  E Revazova; I Bryzgalov; I S Ivanov; J Sebastian; G Keller; J Watson
Journal:  Bull Exp Biol Med       Date:  2001-08       Impact factor: 0.804

7.  Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches.

Authors:  Sarah-Jane Cozzi; Steven M Ogbourne; Cini James; Heggert G Rebel; Frank R de Gruijl; Blake Ferguson; Joy Gardner; Thuy T Lee; Thibaut Larcher; Andreas Suhrbier
Journal:  J Invest Dermatol       Date:  2011-12-22       Impact factor: 8.551

8.  Influence of laser phototherapy (λ660 nm) on the outcome of oral chemical carcinogenesis on the hamster cheek pouch model: histological study.

Authors:  Juliana S de C Monteiro; Ant Nio Luiz Barbosa Pinheiro; Susana C P S de Oliveira; Gilberth T S Aciole; Jos A C Sousa; Maria C T Canguss; Jean Nunes Dos Santos
Journal:  Photomed Laser Surg       Date:  2011-06-30       Impact factor: 2.796

9.  Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC).

Authors:  Jason Martin; F Jason Duncan; Tracy Keiser; Samuel Shin; Donna F Kusewitt; Tatiana Oberyszyn; Abhay R Satoskar; Anne M VanBuskirk
Journal:  FASEB J       Date:  2008-10-24       Impact factor: 5.191

Review 10.  Molecular mechanisms of cell proliferation induced by low power laser irradiation.

Authors:  Xuejuan Gao; Da Xing
Journal:  J Biomed Sci       Date:  2009-01-12       Impact factor: 8.410

View more
  14 in total

1.  Photobiomodulation Therapy Promotes Expansion of Epithelial Colony Forming Units.

Authors:  Imran Khan; Praveen R Arany
Journal:  Photomed Laser Surg       Date:  2016-07-20       Impact factor: 2.796

2.  Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses.

Authors:  Thaís Bianca Brandão; Karina Morais-Faria; Ana Carolina Prado Ribeiro; César Rivera; João Victor Salvajoli; Marcio Ajudarte Lopes; Joel B Epstein; Praveen R Arany; Gilberto de Castro; Cesar Augusto Migliorati; Alan Roger Santos-Silva
Journal:  Support Care Cancer       Date:  2018-02-08       Impact factor: 3.603

3.  Red Light Modulates Ultraviolet-Induced Gene Expression in the Epidermis of Hairless Mice.

Authors:  Max Myakishev-Rempel; Istvan Stadler; Oksana Polesskaya; Alifiya S Motiwala; Frances Barg Nardia; Benjamin Mintz; Ancha Baranova; James Zavislan; Raymond J Lanzafame
Journal:  Photomed Laser Surg       Date:  2015-09-23       Impact factor: 2.796

Review 4.  Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations.

Authors:  Judith A E M Zecha; Judith E Raber-Durlacher; Raj G Nair; Joel B Epstein; Stephen T Sonis; Sharon Elad; Michael R Hamblin; Andrei Barasch; Cesar A Migliorati; Dan M J Milstein; Marie-Thérèse Genot; Liset Lansaat; Ron van der Brink; Josep Arnabat-Dominguez; Lisette van der Molen; Irene Jacobi; Judi van Diessen; Jan de Lange; Ludi E Smeele; Mark M Schubert; René-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2016-03-16       Impact factor: 3.603

Review 5.  "Quantum Leap" in Photobiomodulation Therapy Ushers in a New Generation of Light-Based Treatments for Cancer and Other Complex Diseases: Perspective and Mini-Review.

Authors:  Luis Santana-Blank; Elizabeth Rodríguez-Santana; Karin E Santana-Rodríguez; Heberto Reyes
Journal:  Photomed Laser Surg       Date:  2016-02-18       Impact factor: 2.796

6.  Femtosecond-laser stimulation induces senescence of tumor cells in vitro and in vivo.

Authors:  Xiaohui Zhao; Wanyi Tang; Haipeng Wang; Hao He
Journal:  Biomed Opt Express       Date:  2022-01-14       Impact factor: 3.732

7.  Safety of light emitting diode-red light on human skin: Two randomized controlled trials.

Authors:  Jared Jagdeo; Julie K Nguyen; Derek Ho; Erica B Wang; Evan Austin; Andrew Mamalis; Ramanjot Kaur; Ekaterina Kraeva; Joshua M Schulman; Chin-Shang Li; Samuel T Hwang; Ted Wun; Emanual Maverakis; R Rivkah Isseroff
Journal:  J Biophotonics       Date:  2019-12-08       Impact factor: 3.207

8.  Percutaneous Exposures of volunteers to polychromatic light (480-3400 nm) trigger systemic mechanism of the human myeloma cells growth delay without any effect on bortezomib cytotoxicity in vitro.

Authors:  Natalia V Kalmykova; Anna V Shcherbanyuk; Sergei I Moiseev; Natalia V Bichkova; Natalia I Davidova; Kira A Samoilova
Journal:  Laser Ther       Date:  2019-09-30

Review 9.  Laser Photobiomodulation (PBM)-A Possible New Frontier for the Treatment of Oral Cancer: A Review of In Vitro and In Vivo Studies.

Authors:  Alessandro Del Vecchio; Gianluca Tenore; Maria Clotilde Luzi; Gaspare Palaia; Ahmed Mohsen; Daniele Pergolini; Umberto Romeo
Journal:  Healthcare (Basel)       Date:  2021-01-29

Review 10.  Safety and efficacy of photobiomodulation therapy in oncology: A systematic review.

Authors:  René-Jean Bensadoun; Joel B Epstein; Raj G Nair; Andrei Barasch; Judith E Raber-Durlacher; Cesar Migliorati; Marie-Thérèse Genot-Klastersky; Nathaniel Treister; Praveen Arany; Joy Lodewijckx; Jolien Robijns
Journal:  Cancer Med       Date:  2020-10-26       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.